Evaluation of Flavonoid and Resveratrol Chemical Libraries Reveals Abyssinone II as a Promising Antibacterial Lead

ChemMedChem

Volumn 7, Issue 9, 2012, Pages 1541-1545

  Sun, Dianqing ^a   Hurdle, Julian G ^b   Lee, Robin ^c   Lee, Richard ^c   Cushman, Mark ^d   Pezzuto, John M ^a  

^a UNIVERSITY OF HAWAII AT HILO   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Abyssinone II; Antibacterial agents; Antitubercular agents; Flavonoids; Resveratrol analogues

Indexed keywords

3 HYDROXYFLAVONE; ABYSSINONE 2; ANTIINFECTIVE AGENT; FLAVONE DERIVATIVE; FLAVONOID; ISOFLAVONE DERIVATIVE; NARINGENIN; RESVERATROL; RESVERATROL DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; BACTERIA; BACTERIAL INFECTIONS; FLAVONOIDS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; SMALL MOLECULE LIBRARIES; STILBENES;

EID: 84865598237     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201200253     Document Type: Article

References (40)

1. I. Chopra, C. Schofield, M. Everett, A. O'Neill, K. Miller, M. Wilcox, J. M. Frere, M. Dawson, L. Czaplewski, U. Urleb, P. Courvalin, Lancet Infect. Dis. 2008, 8, 133-139.
2. W. Sougakoff, Clin. Microbiol. Infect. 2011, 17, 800-805.
3. N. Woodford, D. M. Livermore, J. Infect. 2009, 59, S4-16.
4. A. S. Negi, J. K. Kumar, S. Luqman, D. Saikia, P. S. Khanuja, Med. Res. Rev. 2010, 30, 603-645.
5. B. R. Copp, A. N. Pearce, Nat. Prod. Rep. 2007, 24, 278-297.
6. M. T. Gutierrez-Lugo, C. A. Bewley, J. Med. Chem. 2008, 51, 2606-2612.
7. C. Walsh, Nat. Rev. Microbiol. 2003, 1, 65-70.
8. G. J. Kaur, D. S. Arora, BMC Complementary Altern. Med. 2009, 9, 30.
9. M. Cabrera, M. Simoens, G. Falchi, M. L. Lavaggi, O. E. Piro, E. E. Castellano, A. Vidal, A. Azqueta, A. Monge, A. L. deCerain, G. Sagrera, G. Seoane, H. Cerecetto, M. Gonzalez, Bioorg. Med. Chem. 2007, 15, 3356-3367.
10. B. Kosmider, R. Osiecka, Drug Dev. Res. 2004, 63, 200-211.
11. L. L. Song, J. W. Kosmeder II, S. K. Lee, C. Gerhäuser, D. Lantvit, R. C. Moon, R. M. Moriarty, J. M. Pezzuto, Cancer Res. 1999, 59, 578-585.
12. W. Ren, Z. Qiao, H. Wang, L. Zhu, L. Zhang, Med. Res. Rev. 2003, 23, 519-534.
13. L. LeMarchand, Biomed. Pharmacother. 2002, 56, 296-301.
14. D. Tasdemir, G. Lack, R. Brun, P. Ruedi, L. Scapozza, R. Perozzo, J. Med. Chem. 2006, 49, 3345-3353.
15. Z. L. Fowler, K. Shah, J. C. Panepinto, A. Jacobs, M. A. G. Koffas, PLoS One 2011, 6, e25681.
16. T. P. T. Cushnie, A. J. Lamb, Int. J. Antimicrob. Agents 2005, 26, 343-356.
17. P. Erasto, G. Bojase-Moleta, R. R. Majinda, Phytochemistry 2004, 65, 875-880.
18. D. E. Stevenson, R. D. Hurst, Cell. Mol. Life Sci. 2007, 64, 2900-2916.
19. G. DiCarlo, N. Mascolo, A. A. Izzo, F. Capasso, Life Sci. 1999, 65, 337-353.
20. G. R. Beecher, J. Nutr. 2003, 133, 3248S-3254S.
21. L. Marzocchella, M. Fantini, M. Benvenuto, L. Masuelli, I. Tresoldi, A. Modesti, R. Bei, Recent Pat. Inflammation Allergy Drug Discovery 2011, 5, 200-220.
22. I. Erlund, Nutr. Res. 2004, 24, 851-874.
23. K. Horváthová, A. Vachálková, L. Novotný, Neoplasma 2001, 48, 435-441.
24. L. W. Chen, M. J. Cheng, C. F. Peng, I. S. Chen, Chem. Biodiversity 2010, 7, 1814-1821.
25. V. S. Kamat, F. Y. Chuo, I. Kubo, K. Nakanishi, Heterocycles 1981, 15, 1163-1170.
26. A. Maiti, M. Cuendet, V. L. Croy, D. C. Endringer, J. M. Pezzuto, M. Cushman, J. Med. Chem. 2007, 50, 2799-2806.
27. R. L. Farmer, M. M. Biddle, A. E. Nibbs, X. Huang, R. C. Bergan, K. A. Scheidt, ACS Med. Chem. Lett. 2010, 1, 400-405.
28. M. Jang, L. Cai, G. O. Udeani, K. V. Slowing, C. F. Thomas, C. W. W. Beecher, H. H. S. Fong, N. R. Farnsworth, A. D. Kinghorn, R. G. Mehta, R. C. Moon, J. M. Pezzuto, Science 1997, 275, 218-220.
29. J. G. Hurdle, R. B. Lee, N. R. Budha, E. I. Carson, J. Qi, M. S. Scherman, S. H. Cho, M. R. McNeil, A. J. Lenaerts, S. G. Franzblau, B. Meibohm, R. E. Lee, J. Antimicrob. Chemother. 2008, 62, 1037-1045.
30. H. Nikaido, J. Bioenerg. Biomembr. 1993, 25, 581-589.
31. W. W. Yotis, S. I. Baman, Appl. Microbiol. 1970, 19, 474-478.
32. Z. Nowakowska, Eur. J. Med. Chem. 2007, 42, 125-137.
33. M. Feldman, J. Santos, D. Grenier, J. Nat. Prod. 2011, 74, 1862-1867.
34. T. G. Patton, S. J. Yang, K. W. Bayles, Mol. Microbiol. 2006, 59, 1395-1404.
35. J. K. Hobbs, K. Miller, A. J. O'Neill, I. Chopra, J. Antimicrob. Chemother. 2008, 62, 1003-1008.
36. J. G. Hurdle, A. J. O'Neill, I. Chopra, R. E. Lee, Nat. Rev. Microbiol. 2011, 9, 62-75.
37. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard-Seventh Edition, publication ref.: M7-A7, Clinical and Laboratory Standards Institute, Wayne, USA, 2006.
38. M. Wu, E. Maier, R. Benz, R. E. Hancock, Biochemistry 1999, 38, 7235-7242.
39. A. J. O'Neill, K. Miller, B. Oliva, I. Chopra, J. Antimicrob. Chemother. 2004, 54, 1127-1129.
40. B. Oliva, K. Miller, N. Caggiano, A. J. O'Neill, G. D. Cuny, M. Z. Hoemann, J. R. Hauske, I. Chopra, Antimicrob. Agents Chemother. 2003, 47, 458-466.